Kevin B. Alton
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Drug Transport and Resistance Mechanisms, Metabolomics and Mass Spectrometry Studies, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Ezetimibe(2005)468 cited
- → Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663(2000)327 cited
- → In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461(1997)305 cited
- → Intestinal lymphatic transport for drug delivery(2011)269 cited
- Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.(1999)
- → IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL)(2004)177 cited
- → Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects(2002)165 cited
- → Application of Mass Spectrometry for Metabolite Identification(2006)147 cited
- → IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA)(2004)140 cited
- → Liquid Chromatography/Mass Spectrometry Methods for Distinguishing N-Oxides from Hydroxylated Compounds(2000)132 cited